Cell and Process Engineering for Recombinant Antibody Production
Prof DC James
14 December 2018
A vast expansion in the number of recombinant protein therapeutics in development, with a diversification in their molecular architecture necessitates the development of cell and process engineering technologies that can both rapidly generate product and improve manufacturability.
Evolution of Influenza Viruses - prediction of possible future antigenic variants
Prof D Smith
Applications accepted all year round
Evolution of Influenza Viruses. Centre for Pathogen Evolution. Department of Zoology. University of Cambridge. Project summary. Our research focus is to design and develop analytical, computational, and mathematical methods to understand the fundamental processes that govern the evolution of influenza viruses.